CYP2A6 and ERCC1 polymorphisms correlate with efficacy of S-1 plus cisplatin in metastatic gastric cancer patients.

Br J Cancer · 2011 · PMC3068488 · PMID 21364592

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

borderline significanceno p-value reported

In multivariate analysis, the ERCC1 19442C > A genotype was an independent predictor for TTP with borderline significance after adjustment for ECOG performance status, sex, and number of organs with metastases (adjusted HR for patients carrying C/C compared with patients carrying A/A genotype as a reference, was 2.365 (95% CI, 0.909–6.155; P =0.078) ( Table 4 ).

also in 7,017 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.